Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

malignant melanoma

  • Open Access
    Acyclic Retinoid Overcomes Vemurafenib Resistance in Melanoma Cells via Dual Inhibition of MAPK and PI3K/AKT/mTOR Pathways
    YUI SUZUKI, SOICHIRO USUKI, MITSUAKI NISHIZAWA, NORIYOSHI TANAKA, YOSHITOMO SUHARA and ICHIRO YAJIMA
    Anticancer Research June 2025, 45 (6) 2265-2278; DOI: https://doi.org/10.21873/anticanres.17601
  • You have access
    Antitumor Activity of Ex Vivo Expanded Tumor Antigen Priming Cytotoxic T Cells Against Malignant Melanoma
    HOE-SUN YOON, YOUNG GYU PARK, DAE YOEN CHO, JONG-SEOK KIM and JONG GWON CHOI
    Anticancer Research June 2025, 45 (6) 2339-2350; DOI: https://doi.org/10.21873/anticanres.17607
  • Open Access
    Malignant Melanoma: Vitamin D Status as a Risk and Prognostic Factor – Meta-analyses and Systematic Review
    SINAN HADDAD, JULIUS JOHANNES WEISE, STEFAN WAGENPFEIL, THOMAS VOGT and JOERG REICHRATH
    Anticancer Research January 2025, 45 (1) 27-37; DOI: https://doi.org/10.21873/anticanres.17390
  • Open Access
    Resveratrol Can Differentiate Human Melanoma Stem-like Cells from Spheroids Treated With All-trans Retinoic Acid
    MINA KANAI, AKIHO SHINAGAWA, MASAKO OTA, NANTIGA VIRGONA and TOMOHIRO YANO
    Anticancer Research December 2024, 44 (12) 5283-5292; DOI: https://doi.org/10.21873/anticanres.17356
  • You have access
    Gene Profiling of Cannabis-sativa-mediated Apoptosis in Human Melanoma Cells
    KANITA POOMMARAPAN, PAISAL RUMMANEETHORN, ATTASIT SRISUBAT, NUNTAKAN SUWANPIDOKKUL, PETCHPAILIN LEENUTAPHONG, THAMTHIWAT NARARATWANCHAI, SIRADA SRIHIRUN, WANTHANEE PHETCHENGKAO, KANKANIT SURIYACHAN and SALUNYA TANCHAROEN
    Anticancer Research March 2023, 43 (3) 1221-1237; DOI: https://doi.org/10.21873/anticanres.16269
  • Open Access
    CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells
    NAHO FUJII, MASAKAZU YASHIRO, TAKAHARU HATANO, HEISHIRO FUJIKAWA and HISASHI MOTOMURA
    Anticancer Research January 2023, 43 (1) 25-33; DOI: https://doi.org/10.21873/anticanres.16130
  • You have access
    Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
    CARSTEN NIEDER, SIV GYDA AANES and ELLINOR C. HAUKLAND
    Anticancer Research June 2022, 42 (6) 3061-3066; DOI: https://doi.org/10.21873/anticanres.15793
  • You have access
    Nivolumab for the Treatment of Advanced Pediatric Malignancies
    AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI and JAN STYCZYŃSKI
    Anticancer Research December 2020, 40 (12) 7095-7100; DOI: https://doi.org/10.21873/anticanres.14738
  • You have access
    Melanoma Risk Estimation Based on Objective Measures as a Complement to Self-Assessment
    ADAM CARLSSON and MAGNUS FALK
    Anticancer Research June 2020, 40 (6) 3325-3331; DOI: https://doi.org/10.21873/anticanres.14315
  • You have access
    National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma
    MARIA T. HUAYLLANI, DAVID J. RESTREPO, DANIEL BOCZAR, FRANCISCO R. AVILA, SANJAY P. BAGARIA, AARON C. SPAULDING, BRIAN D. RINKER and ANTONIO J. FORTE
    Anticancer Research June 2020, 40 (6) 3411-3415; DOI: https://doi.org/10.21873/anticanres.14325

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire